Skip to main content
. 2020 Sep 30;19:127–135. doi: 10.1016/j.omto.2020.09.007

Figure 3.

Figure 3

Dose-Dependent Anti-Tumor Effect of rMV-SLAMblind in a Xenograft Model

rMV-LUC-SLAMblind was once administered to the tumor of MDA-MB-468 xenografts. (A) Luciferase activity was shown as the average + SD. (B) Bioluminescent images of the mice at 23 dpi are shown. (C) Tumor volume of individual mice (n = 3) was plotted with the average. ∗p < 0.05, Welch’s t test.